课题基金 / 基金详情

DIMERIZATION OF TRANSCOBALAMIN II RECEPTOR

DIMERIZATION OF TRANSCOBALAMIN II RECEPTOR
转钴胺素 II 受体的二聚化
批准号:
6118860
负责人:
Santanu Bose
金额:
$0.31万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-03-01 至 2000-02-29

项目摘要

项目成果

Santanu Bose的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Transcobalamin II receptor (TC II-R) exists as a monomer and a dimer of molecular masses of 62 and 124 kDa in the microsomal and plasma membranes, respectively. In vivo, pure TC II-R monomer dimerizes upon insertion into egg PC/cholesterol (41) liposomes. The current studies were carried out to define the mechanism of TC II-R dimerization. Both enzymatically deglycosylated (45-47 kDa) and mature pure TC II-R (62 kDa) demonstrated optimal association and formed dimers of molecular mass of 95 and 124 kDa, respectively, at 22?C in association with egg PC vesicles containing at least 10 mole% of cholesterol. Mature receptor also dimerized upon insertion into dimyristoyl phosphatidylcholine vesicles at 5?C in the absence of cholesterol or at 22?C with lipid vesicles prepared using lipid extract from the plasma, but not microsomal membranes. Cholesterol depletion of native intestinal plasma membranes or its enrichment of microsomal membranes resulted in the in situ conver sio n of the 124 kDa dimer to the 62 kDa monomer or of the monomer into the dimer form, respectively. Treatment of the plasma membranes with phospholipase A2 resulted in the in situ conversion of the dimer form of the receptor to the monomer form. Spin-label studies using 1-palmitoyl, 12 doxylsteroyl PC revealed that interactions with TC II-R increased order around the probe. Based on these results, we suggest that dimerization of TC II-R is 1) mediated by its interactions with a rigidly more ordered lipid bilayer membrane; 2) in plasma membranes, is regulated by cholesterol levels; and 3) is independent of glycosylation-mediated folding.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mycoplasma pneumoniae CARDS toxin mediated ADP-ribosylation of NLRP3 inflammasome
Mycoplasma pneumoniae CARDS toxin mediated ADP-ribosylation of NLRP3 inflammasome
Host defense against respiratory virus infections
  • 批准号:
    8828325
  • 项目类别:
  • 资助金额:
    $6.71万
  • 财政年份:
    2010
  • 负责人:
    Santanu Bose
  • 依托单位:
Host defense against respiratory virus infections
海外基金